2.6. Exploring the Predictive Role of GALNT14-rs62139523 “A/G” Genotype in Favorable OS and PFS across Subgroups in Intermediate-Stage CRC Patients Undergoing Surgical Resection Followed by 5-FU-Based Adjuvant Chemotherapy. This evidence concerns the gene GALNT14 and colorectal carcinoma.